Not yet a member?Join now!|Lost password
Isis Pharmaceuticals Inc.
Isis Pharmaceuticals Inc.
07/23/2012 | Press release
Webcast Alert: Isis Pharmaceuticals' Second Quarter 2012 Financial Results Conference Call
distributed by noodls on 07/23/2012 08:13
CARLSBAD, Calif., July 23, 2012/PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announces the following webcast:
|
What: |
Isis Pharmaceuticals' Second Quarter 2012 Financial Results Conference Call |
|
When: |
Monday, August 6, 2012 at 11:30 a.m. ET / 8:30 a.m. PT |
|
Where: |
|
|
How: |
Live on the Internet. Simply log onto our Web site listed above. |
|
Contacts: |
Kristina Lemonidis |
|
Amy Blackley, Ph.D. |
If you are unable to participate during the live event, a replay of the webcast will be available for a limited time at www.isispharm.com.
ABOUT ISIS PHARMACEUTICALS, INC.
Isis is exploiting its leadership position in antisense
technology to discover and develop novel drugs for its
product pipeline and for its partners. Isis' broad
pipeline consists of 25 drugs to treat a wide variety of
diseases with an emphasis on cardiovascular, metabolic,
severe and rare diseases, and cancer. Isis'
partner, Genzyme, plans to commercialize Isis' lead
product, KYNAMRO™, in the United Statesand
Europefollowing regulatory approval, which is
expected in 2012. Isis' patents provide strong and
extensive protection for its drugs and technology.
Additional information about Isis is available at . www.isispharm.com
SOURCE Isis Pharmaceuticals, Inc.
